Molecure S.A. Total Liabilities

Latest as of March 2025: zł9.24 Million PLN ≈ $2.54 Million USD

Molecure S.A. total liabilities. Based on the latest financial reports, Molecure S.A. (MOC) has total liabilities worth zł9.24 Million PLN (≈ $2.54 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See Molecure S.A. (MOC) liquidity interval to measure how many days the company can operate on defensive assets alone.

Total Liabilities of Molecure S.A. (2014–2024)

Total liabilities of Molecure S.A. from 2014 to 2024. This chart illustrates how Molecure S.A.'s total liabilities have evolved over time, based on quarterly financial data.

Molecure S.A. Competitors by Total Liabilities

The table below lists competitors of Molecure S.A. ranked by their total liabilities.

Company	Country	Total Liabilities
Apollomics Inc. Class A Ordinary Shares NASDAQ:APLM	USA	$9.90 Million
Cayman Tung Ling Co Ltd TWO:2924	Taiwan	NT$485.00 Million
Scanwolf Corporation Bhd KLSE:7239	Malaysia	RM135.22 Million
Shanghai Sanmao Enterprise Group Co Ltd B SHG:900922	China	$499.17 Million
Columbus Acquisition Corp Unit NASDAQ:COLAU	USA	$310.21K
Next Science Ltd AU:NXS	Australia	AU$10.02 Million
CZR Resources Ltd AU:CZR	Australia	AU$5.63 Million
Yellow Balloon Tour Co. Ltd KQ:104620	Korea	₩64.96 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Molecure S.A.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Molecure S.A. (MOC) total assets.

Liquidity & Leverage Metrics

Molecure S.A. Total Liabilities Ratios Explained

Molecure S.A. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	10.28	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.09	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.09	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Molecure S.A.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Molecure S.A. (2014–2024)

The table below shows the annual total liabilities of Molecure S.A. from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	zł10.31 Million ≈ $2.84 Million	-9.09%
2023-12-31	zł11.34 Million ≈ $3.12 Million	-2.31%
2022-12-31	zł11.61 Million ≈ $3.20 Million	+11.16%
2021-12-31	zł10.45 Million ≈ $2.88 Million	+3.49%
2020-12-31	zł10.09 Million ≈ $2.78 Million	+53.94%
2019-12-31	zł6.56 Million ≈ $1.80 Million	+59.00%
2018-12-31	zł4.12 Million ≈ $1.14 Million	-14.91%
2017-12-31	zł4.85 Million ≈ $1.33 Million	+93.30%
2016-12-31	zł2.51 Million ≈ $690.16K	+129.40%
2015-12-31	zł1.09 Million ≈ $300.86K	+95.19%
2014-12-31	zł560.05K ≈ $154.13K	--

About Molecure S.A.

WAR:MOC Poland Biotechnology

Market Cap

$30.05 Million

zł109.20 Million PLN

Market Cap Rank

#23580 Global

#229 in Poland

Share Price

zł5.30

Change (1 day)

-1.85%

52-Week Range

zł5.11 - zł8.68

All Time High

zł69.60